|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Aimmune Therapeutics, Inc. (AIMT) |
|
|
$34.49 0.00 (0.00%) as of 4:30 Mon 10/12
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
63,299,000 |
| Market
Cap: |
2.18(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$34.49 - $34.49 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nestle Sa |
10% Owner |
– – • |
2020-04-22 |
4 |
A |
$161.10 |
$84,679,637 |
I/I |
525,634 |
525,634 |
|
- |
|
| Nestle Sa |
10% Owner |
– – • |
2020-04-22 |
4 |
A |
$16.11 |
$205,033,790 |
I/I |
12,727,113 |
12,727,113 |
|
- |
|
| Enright Patrick G |
Director |
– • – |
2020-03-18 |
4 |
B |
$11.06 |
$179,345 |
D/D |
16,213 |
70,561 |
2.39 |
18% |
|
| Enright Patrick G |
Director |
– • – |
2020-03-17 |
4 |
B |
$11.50 |
$101,051 |
D/D |
8,787 |
54,348 |
2.39 |
27% |
|
| Enright Patrick G |
Director |
– • – |
2020-03-17 |
4 |
B |
$11.40 |
$1,139,650 |
I/I |
100,000 |
6,113,134 |
2.1 |
27% |
|
| Oxtoby Andrew |
Chief Commercial Officer |
• – – |
2020-03-13 |
4 |
B |
$14.76 |
$44,266 |
D/D |
3,000 |
25,015 |
2.74 |
-1% |
|
| Bjerkholt Eric |
Chief Financial Officer |
• – – |
2020-03-12 |
4 |
B |
$15.10 |
$15,100 |
D/D |
1,000 |
42,967 |
2.74 |
7% |
|
| Dallas Jayson Donald Alexander |
President and CEO |
• • – |
2020-03-10 |
4 |
B |
$18.74 |
$49,934 |
D/D |
2,665 |
123,283 |
2.81 |
-18% |
|
| Bjerkholt Eric |
Chief Financial Officer |
• – – |
2020-03-09 |
4 |
B |
$18.97 |
$18,970 |
D/D |
1,000 |
41,967 |
2.74 |
-29% |
|
| Dallas Jayson Donald Alexander |
President and CEO |
• • – |
2020-03-02 |
4 |
D |
$23.81 |
$73,359 |
D/D |
(3,081) |
120,618 |
|
- |
|
| Sheehy Douglas T. |
See Remarks |
• – – |
2020-03-02 |
4 |
D |
$23.81 |
$94,288 |
D/D |
(3,960) |
52,958 |
|
- |
|
| Adelman Daniel C Md |
Chief Medical Officer |
• – – |
2020-03-02 |
4 |
D |
$23.81 |
$44,572 |
D/D |
(1,872) |
27,295 |
|
- |
|
| Bjerkholt Eric |
Chief Financial Officer |
• – – |
2020-03-02 |
4 |
D |
$23.81 |
$47,191 |
D/D |
(1,982) |
40,967 |
|
- |
|
| Oxtoby Andrew |
Chief Commercial Officer |
• – – |
2020-02-28 |
4/A |
A |
$0.00 |
$0 |
D/D |
11,250 |
22,015 |
|
- |
|
| Bjerkholt Eric |
Chief Financial Officer |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,375 |
42,949 |
|
- |
|
| Adelman Daniel C Md |
Chief Medical Officer |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,750 |
29,167 |
|
- |
|
| Oxtoby Andrew |
Chief Commercial Officer |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
11,250 |
23,250 |
|
- |
|
| Sheehy Douglas T. |
See Remarks |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
11,250 |
56,918 |
|
- |
|
| Dallas Jayson Donald Alexander |
President and CEO |
• • – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
123,699 |
|
- |
|
| Nestle Sa |
10% Owner |
– – • |
2020-02-07 |
4 |
B |
$319.68 |
$168,032,049 |
I/I |
525,634 |
525,634 |
1.5 |
-32% |
|
| Nestle Sa |
10% Owner |
– – • |
2020-02-07 |
4 |
B |
$31.97 |
$31,970,000 |
I/I |
1,000,000 |
12,727,113 |
1.5 |
-32% |
|
| Oxtoby Andrew |
Chief Commercial Officer |
• – – |
2020-01-22 |
4 |
D |
$33.23 |
$41,039 |
D/D |
(1,235) |
10,765 |
|
- |
|
| Sheehy Douglas T. |
See Remarks |
• – – |
2020-01-16 |
4 |
AS |
$37.00 |
$14,800 |
D/D |
(400) |
45,668 |
|
-53% |
|
| Sheehy Douglas T. |
See Remarks |
• – – |
2020-01-16 |
4 |
OE |
$12.95 |
$5,180 |
D/D |
400 |
46,068 |
|
- |
|
| Adelman Daniel C Md |
Chief Medical Officer |
• – – |
2020-01-02 |
4 |
AS |
$35.00 |
$700,038 |
D/D |
(20,000) |
21,250 |
|
-47% |
|
268 Records found
|
|
Page 3 of 11 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
